ID   G19-4
AC   CVCL_XC65
SY   HB G19-4
DR   CCRID; 4201PAT-CCTCC00045
DR   Wikidata; Q93558233
RX   Patent=US6010902;
RX   PubMed=3084650;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9536.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human CD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
RX   Patent=US6010902;
RA   Ledbetter J.A., Gilliland L.K.;
RT   "Antibody heteroconjugates and bispecific antibodies for use in
RT   regulation of lymphocyte activity.";
RL   Patent number US6010902, 04-Jan-2000.
//
RX   PubMed=3084650; DOI=10.4049/jimmunol.136.11.3945;
RA   Ledbetter J.A., June C.H., Martin P.J., Spooner C.E., Hansen J.A.,
RA   Meier K.E.;
RT   "Valency of CD3 binding and internalization of the CD3 cell-surface
RT   complex control T cell responses to second signals: distinction
RT   between effects on protein kinase C, cytoplasmic free calcium, and
RT   proliferation.";
RL   J. Immunol. 136:3945-3952(1986).
//